Ascendis Pharma A/S
ASND
|
|
| |
|
| Trading Volume | 11,015 |
|
|
159.40 - 86.10 |
| Market Cap Full | $ 7.7B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 2.1% | 20.1% | -12.2% | -12.8% |
| Q2 | - | -10.8% | -16.8% | -20.8% |
| Q3 | - | 9.2% | 4.9% | 11.1% |
| Q4 | - | 10.9% | 38.2% | 18.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 3.2 | 13.7 | 2.3 | -7.2 | -3.5 | 0.2 | - | - | - | - | - | 1 |
| 2023 | |||||||||||
| 1.6 | -10.5 | -3.5 | -34.8 | 24.3 | 2.6 | 1 | 8.7 | -4.5 | -4.6 | 12.5 | 25.4 |
| 2022 | |||||||||||
| -9.6 | -7.6 | 4.4 | -22.2 | -7.4 | 10 | -8 | 4.7 | 15.3 | 11.4 | 7 | -0.8 |
| 2021 | |||||||||||
| -9.8 | 3.2 | -16.8 | 13.6 | -8.2 | -2.1 | -11.5 | 34.6 | 1.9 | -4.3 | -10.3 | -1.8 |
| 2020 | |||||||||||
| -1.6 | -5.6 | -11.9 | 20.5 | 7.2 | 1.7 | -7 | 7.7 | 4.1 | 5.9 | 3.3 | -1.4 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -2.1 | -2.5 | -1.4 | -1.5 |
| Q2 | -2.4 | -1.6 | -3 | -2.2 |
| Q3 | -3.1 | -3.1 | -1.7 | -2.7 |
| Q4 | 0 | -3.9 | -2.1 | -3.1 |
| A | -7.63 | -11 | -8.3 | -9.46 |